We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Thales AVS France


Offers diagnostic imaging products, including FCR” digital x-ray imaging and diagnostic systems, “Synapse” medical-us... read more Featured Products: More products

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Fujifilm Introduces AI-Powered Chest X-Ray Software in Collaboration with Lunit

By MedImaging International staff writers
Posted on 17 Aug 2021
Print article
Fujifilm Corporation (Tokyo, Japan) has announced that its software for analyzing chest X-ray developed with the core artificial intelligence (AI) technology of Lunit (Seoul, Korea) will be commercially available across Japan.

The AI-powered product named CXR-AID is designed to better detect major abnormal findings such as chest nodule, consolidation, and pneumothorax from chest X-ray images. Findings detected by the AI software are shown in color as a heatmap display, with each score included. Through this solution, doctors and medical professionals are able to reduce missed cases and effectively diagnose chest diseases from chest X-ray.

The PMDA approved AI-powered software is developed with Lunit’s core AI technology and is provided with Fujifilm's PACS system(SYNAPSE) and to be distributed across hospitals and medical institutions of Japan for more efficient diagnosis. With Lunit AI connected to Fujifilm's PACS system and X-ray devices, the AI products are distributed across its global customers and networks.

Lunit AI is also applied in Fujifilm's mobile X-ray device (FDR nano) and portable X-ray devices (FDR Xair), General X-ray device (FDR Smart X), and is in use in clinical settings to detect COVID-19 symptoms and tuberculosis in regions where there are a limited number of doctors.

"We strongly believe that sooner or later AI will become the new standard of care, and AI will be used everywhere as a must-use product," said Brandon Suh, CEO of Lunit. "Not only will it be used as a tool to make the workflow more efficient, but it will ensure better diagnosis and healthier life for patients. We are glad to make this happen with Fujifilm, and will accelerate our expansion with its global network."

Related Links:
Fujifilm Corporation

Print article
Sun Nuclear


Imaging IT

view channel

Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology

The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.